ReviewPain2026
Preclinical models of female pelvic pain disorders.
Review in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractPain is influenced by a complex interplay of biological, psychological, and social factors. Sex has emerged as a key determinant of vulnerability to chronic pain and a major risk factor for poor response to available pharmacological treatments. Women report higher rates of chronic pain and exhibit greater pain sensitivity; however, the underlying mechanisms remain poorly understood. Preclinical models are essential to uncover sex-specific biological pathways involved in pain and to guide the development of novel, targeted therapies through translational approaches. This review summarizes animal models of female-associated pelvic pain disorders, including endometriosis, adenomyosis, dysmenorrhea, vulvodynia, interstitial cystitis, uterine leiomyomas, chronic pelvic pain, and pelvic inflammatory disease. These models recapitulate key features such as lesion biology, neuroimmune interactions, and pain behaviors also observed in patients. However, current models still face limitations in capturing spontaneous pain dynamics, hormonal complexity, and psychosocial influences. Refining and integrating biological, behavioral, and sex-specific endpoints will be crucial to enhance their translational relevance and advance precision pain therapies for women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.